8-KExhibits & Filings

WELLS FARGO & COMPANY/MN 8-K Report, Exhibit Filing (Apr 23, 2014)

Filed April 23, 2014For Securities:WFCWFC-PDWFC-PCWFC-PYWFC-PAWFC-PLWFCNPWFC-PZ

Summary

This 8-K filing from Wells Fargo & Company, filed on April 22, 2014, pertains to an amendment and restatement of its Medium-Term Notes, Series K, 0.125% Exchangeable Notes due March 2, 2016. The company entered into a Fifth Supplemental Indenture with Citibank, N.A. on April 21, 2014, to update the terms of these existing notes. For investors holding these specific notes, the primary takeaway is the formal restatement of terms. The filing provides details on the supplemental indenture and the amended note form, along with legal opinions and consents from external counsel. While this filing does not announce new debt issuance or material financial performance changes, it is a procedural update regarding existing debt instruments.

Key Highlights

  • 1Wells Fargo & Company amended and restated its Medium-Term Notes, Series K, 0.125% Exchangeable Notes due March 2, 2016.
  • 2The amendment was formalized through a Fifth Supplemental Indenture entered into with Citibank, N.A., acting as trustee.
  • 3The event date for this action was April 21, 2014, and the filing occurred on April 22, 2014.
  • 4The filing includes the Fifth Supplemental Indenture as an exhibit.
  • 5The amended and restated note form is also provided as an exhibit.
  • 6Legal opinions from Faegre Baker Daniels LLP and Davis Polk & Wardwell LLP regarding the notes are included.
  • 7Consents from the aforementioned legal firms are also filed as exhibits.

Frequently Asked Questions